Potential New Nasal Spray for Patients Suffering from Chronic Sinusitis

This blog is an OPINION and not medical advice. If there are any questions, please see your physician.

Accentia Pharmaceuticals is in the process of testing a new nasal spray called SinuNase which contains the active ingredient Amphotericin B. Why is this medication of interest to an ENT? Well, it would be one potential treatment for patients with chronic rhinosinusitis in which airborne fungus is the underlying cause of persistent sinusitis in spite of adequate antibiotic and surgical treatment.

This medication is currently undergoing Phase III FDA approval.